Magnetar Financial LLC Beam Therapeutics Inc. Transaction History

Magnetar Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$23.01 - $32.46 $143,927 - $203,037	6,255 Added 20.91%	36,172 $869,000
Q2 2023 Aug 11, 2023	SELL	$29.32 - $35.99 $320,321 - $393,190	-10,925 Reduced 26.75%	29,917 $955,000
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $888,520 - $1.44 Million	29,470 Added 259.15%	40,842 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $417,693 - $586,795	11,372 New	11,372 $445,000
Q1 2022 May 16, 2022	SELL	$53.73 - $82.16 $671,087 - $1.03 Million	-12,490 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$68.02 - $99.06 $849,569 - $1.24 Million	12,490 New	12,490 $995,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.